The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MorphoSys
 
Honoraria - Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Janssen; Roche
Research Funding - Gilead Sciences; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Roche; Takeda
 
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Roche
B-MIND: MOR208 plus bendamustine (BEN) versus rituximab (RTX) plus BEN in patients with relapsed or refractory (R-R) diffuse large B-cell lymphoma (DLBCL): An open-label, randomized phase II/III trial.
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene; MorphoSys
Research Funding - Celgene (Inst)
 
David Belada
No Relationships to Disclose
 
Lysianne Molina
Travel, Accommodations, Expenses - Novartis
 
Katerina Kopeckova
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly; Pfizer
Travel, Accommodations, Expenses - Bayer; Pfizer
 
Kamel Laribi
Honoraria - Amgen; Novartis; Takeda
Research Funding - Amgen; Hospira; Janssen-Cilag; Mundipharma; Novartis; Roche; Takeda; Teva
 
Raquel del Campo Garcia
No Relationships to Disclose
 
Bertrand Coiffier
Consulting or Advisory Role - Celgene; Celltrion; ERYTECH Pharma; MorphoSys; Mundipharma; Novartis; Pfizer; Roche; Takeda
Research Funding - Celgene (Inst)
Expert Testimony - Gilead Sciences
 
Wojciech Jurczak
Consulting or Advisory Role - MorphoSys; Sandoz-Novartis
Research Funding - Abbvie; AstraZeneca; Bayer; Celltrion; Gilead Sciences; Janssen; Merck; MorphoSys; Roche; Sandoz-Novartis; Takeda
 
Mathias J. Rummel
No Relationships to Disclose
 
Georg Hess
Honoraria - Celgene; Janssen; MorphoSys; Novartis; Roche
Consulting or Advisory Role - Celgene; Janssen; MorphoSys; Novartis; Roche
Research Funding - Celgene (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen; Roche
 
Andreas Rosenwald
Consulting or Advisory Role - Janssen; MorphoSys; Roche
 
Mark Winderlich
Employment - MorphoSys
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Roman Korolkiewicz
No Relationships to Disclose
 
Pier Luigi Zinzani
No Relationships to Disclose